Wealthspire Advisors (New York)’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-268
Closed -$52.5K 2972
2025
Q3
$52.5K Buy
+268
New +$44.1K ﹤0.01% 1233

Other funds holding ALAB

Wealthspire Advisors (New York)'s ALAB Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 268 shares — an estimated $52.5K sold.

Wealthspire Advisors (New York) first reported a position in ALAB in Q3 2025 and held it in 1 quarter. The position peaked at $52.5K in Q3 2025. 702 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 268 Astera Labs shares in Q4 2025, an estimated $52.5K.
  • Wealthspire Advisors (New York) first reported a position in Astera Labs in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Astera Labs position peaked at $52.5K in Q3 2025.
  • 702 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.